Show simple item record

dc.contributor.authorBennett, Nitasha R
dc.contributor.authorJarvis, Cassie Marie.
dc.contributor.authorAlam, Mohammad Murshid
dc.contributor.authorZwick, Daniel B
dc.contributor.authorOlson, Jake M
dc.contributor.authorNguyen, Hung V.-T.
dc.contributor.authorJohnson, Jeremiah A.
dc.contributor.authorCook, Mark E
dc.contributor.authorKiessling, Laura L
dc.date.accessioned2021-01-19T20:19:32Z
dc.date.available2021-01-19T20:19:32Z
dc.date.issued2019-10
dc.identifier.issn1525-7797
dc.identifier.issn1526-4602
dc.identifier.urihttps://hdl.handle.net/1721.1/129449
dc.description.abstractSubunit vaccines can have excellent safety profiles, but their ability to give rise to robust immune responses is often compromised. For glycan-based vaccines, insufficient understanding of B and T cell epitope combinations that yield optimal immune activation hinders optimization. To determine which antigen features promote desired IgG responses, we synthesized epitope-functionalized polymers using ring-opening metathesis polymerization (ROMP) and assessed the effect of B and T cell epitope loading. The most robust responses were induced by polymers with a high valency of B and T cell epitopes. Additionally, IgG responses were greater for polymers with T cell epitopes that are readily liberated upon endosomal processing. Combining these criteria, we used ROMP to generate a nontoxic, polymeric antigen that elicited stronger antibody responses than a comparable protein conjugate. These findings highlight principles for designing synthetic antigens that elicit strong IgG responses against inherently weak immune targets such as glycans.en_US
dc.description.sponsorshipNational Institutes of Health (AI055258)en_US
dc.language.isoen
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionof10.1021/ACS.BIOMAC.9B01049en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceProf. Kiessling via Ye Lien_US
dc.titleModular polymer antigens to optimize immunityen_US
dc.typeArticleen_US
dc.identifier.citationBennett, Nitasha R. et al. "Modular polymer antigens to optimize immunity." Biomacromolecules 20, 12 (October 2019): 4370-79 ©2019 American Chemical Societyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalBiomacromoleculesen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-10-14T16:28:39Z
dspace.date.submission2020-10-14T16:28:51Z
mit.journal.volume20en_US
mit.journal.issue12en_US
mit.licensePUBLISHER_POLICY
mit.metadata.statusComplete


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record